Published in N Engl J Med on March 27, 1986
Additional endoscopic procedures instead of urgent surgery for retained common bile duct stones. Gut (1989) 1.29
General surgery: biliary surgery. BMJ (1993) 1.27
A retrospective analysis of 3 year's experience of an interdisciplinary approach to gallstone disease including shock-waves. Ann Surg (1988) 1.19
Selective ERCP and preoperative stone removal in bile duct surgery. Ann Surg (1989) 1.09
Tissue reactions under piezoelectric shockwave application for the fragmentation of biliary calculi. Gut (1989) 1.06
Non-surgical treatment of gall stones: many contenders but who will win the crown? Gut (1988) 1.05
Extracorporeal shock-wave lithotripsy of bile duct calculi. An interim report of the Dornier U.S. Bile Duct Lithotripsy Prospective Study. Ann Surg (1989) 1.03
Choledochoscopic electrohydraulic lithotripsy and lithotomy for stones in the common bile duct, intrahepatic ducts, and gallbladder. Ann Surg (1989) 1.02
A multivariate analysis of preoperative risk factors in patients with common bile duct stones. Implications for treatment. Ann Surg (1989) 0.99
Laserlithotripsy of common bile duct stones. Gut (1988) 0.99
Extracorporeal lithotripsy of pancreatic stones in patients with chronic pancreatitis and pain: a prospective follow up study. Gut (1992) 0.99
Comparison of gall bladder bile and endoscopically obtained duodenal bile. Gut (1990) 0.97
Extracorporeal shockwave lithotripsy of gallstones. Possibilities and limitations. Ann Surg (1989) 0.93
How Should Biliary Stones be Managed? Gut Liver (2010) 0.92
Percutaneous cholecystolithotomy. Br Med J (Clin Res Ed) (1988) 0.92
Effects of cholecystectomy on the kinetics of primary and secondary bile acids. J Clin Invest (1989) 0.92
Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am (2010) 0.90
Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther (2012) 0.90
Extracorporeal shock wave lithotripsy of bile duct stones: a single institution experience. Gut (1992) 0.87
Aggressive extracorporeal shock wave lithotripsy of gall bladder stones within wider treatment criteria: fragmentation rate and early results. Gut (1992) 0.85
In vitro interaction of lithotripter shock waves and cytotoxic drugs. Br J Cancer (1992) 0.85
Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey. Dig Dis Sci (1998) 0.85
Pulverisation of calcified and non-calcified gall bladder stones: extracorporeal shock wave lithotripsy used alone. Gut (1994) 0.83
Extracorporeal shock wave lithotripsy (ESWL) in the management of complex biliary tract stone disease. Ann Surg (1988) 0.82
Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy. Gut (1992) 0.82
Lithotripsy of an impacted calcified stone in the cystic duct accompanied by cholecystitis in severe Crohn's disease. Gut (1993) 0.80
Extracorporeal shock wave lithotripsy of gall stones: an in vitro comparison between an electrohydraulic and a piezoceramic device. Gut (1991) 0.79
Update on endoscopic management of main pancreatic duct stones in chronic calcific pancreatitis. Korean J Intern Med (2012) 0.78
Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review. Dig Dis Sci (2008) 0.78
Extra-corporeal shock wave lithotripsy. Postgrad Med J (1987) 0.77
Piezoelectric lithotripsy and soft tissue injury. Safety limits in the experimental and clinical setting. Gut (1990) 0.76
What should I do about my patient's gall stones? Postgrad Med J (1995) 0.75
Dissolution of cholesterol gall stones using methyltertbutyl ether: a safe effective treatment. Gut (1991) 0.75
Extracorporeal shock wave lithotripsy for gallstones. J R Soc Med (1990) 0.75
Computed tomographic analysis of gallbladder stones: correlation with chemical composition and in vitro shock-wave lithotripsy. Korean J Intern Med (1991) 0.75
Endoscopic treatment of pancreatic calculi. Clin Endosc (2014) 0.75
Shock news for gall stones. Br Med J (Clin Res Ed) (1987) 0.75
Relief of heterogeneous symptoms after successful gall bladder stone lithotripsy and complete stone disappearance. Gut (1994) 0.75
Shock-wave lithotripsy of gallbladder stones. The first 175 patients. N Engl J Med (1988) 5.53
Extracorporeally induced destruction of kidney stones by shock waves. Lancet (1980) 4.25
First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol (1982) 3.14
Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science (1984) 2.75
The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature (1989) 2.75
A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology (1984) 2.70
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol (2000) 2.58
Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol (2002) 2.54
Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res (1998) 2.35
A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut (1997) 2.32
Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A (1991) 2.32
A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med (2000) 2.20
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med (2001) 2.12
Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09
Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology (1993) 2.08
Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry (1999) 2.07
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
Clostridium difficile infection in patients with neutropenia. Clin Infect Dis (2001) 2.00
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med (2001) 2.00
Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut (2005) 1.99
Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry (1997) 1.96
Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients. Support Care Cancer (2002) 1.95
Genetics of the apolipoprotein E system in man. Am J Hum Genet (1980) 1.94
T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia. Hepatology (1996) 1.88
Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation. J Biol Chem (1984) 1.80
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest (1981) 1.79
Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol (1991) 1.76
Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology (1992) 1.70
Dormia baskets impacted in the bile duct: release by extracorporeal shock-wave lithotripsy. Endoscopy (1995) 1.70
Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection. Eur J Clin Invest (1999) 1.68
Processing of yeast mitochondrial RNA: involvement of intramolecular hybrids in splicing of cob intron 4 RNA by mutation and reversion. Cell (1983) 1.66
Estimating the cost of developmental and behavioral screening of preschool children in general pediatric practice. Pediatrics (2001) 1.65
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Comparison of capsule endoscopy and magnetic resonance imaging for the detection of polyps of the small intestine in patients with familial adenomatous polyposis or with Peutz-Jeghers' syndrome. Endoscopy (2004) 1.64
Gallstones: pathogenesis. Lancet (1991) 1.64
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med (1999) 1.63
Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol (2011) 1.62
Uptake of bile acids by perfused rat liver. Am J Physiol (1976) 1.61
Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology (1996) 1.61
Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med (1997) 1.61
Gallstone recurrence after shock-wave therapy. Gastroenterology (1994) 1.59
Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer (2003) 1.57
A pilot study of neuropsychological function in girls with ADHD. J Am Acad Child Adolesc Psychiatry (1997) 1.56
Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry. JAMA (1967) 1.54
Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy (2002) 1.51
Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem (2001) 1.50
Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol (2001) 1.47
Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology (1991) 1.47
Patient controlled analgesia for extracorporeal shock wave lithotripsy of gallstones. Pain (1992) 1.47
Production of an epidermal growth factor receptor-related protein. Science (1984) 1.46
Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis. Am J Gastroenterol (2000) 1.46
[Symptoms, tumor stage and primary treatment in patients with colorectal carcinoma]. Dtsch Med Wochenschr (1997) 1.46
Glutathione protects the rat liver against reperfusion injury after hypothermic preservation. Gastroenterology (1999) 1.45
Psychiatric, neuropsychological, and psychosocial features of DSM-IV subtypes of attention-deficit/hyperactivity disorder: results from a clinically referred sample. J Am Acad Child Adolesc Psychiatry (1998) 1.45
[Metabolic products of microorganisms. 175. Tetracenomycin C (author's transl)]. Arch Microbiol (1979) 1.44
Investigation of cavitation in flowing media by lithotripter shock waves both in vitro and in vivo. Ultrasound Med Biol (1989) 1.44
Surgical intervention following fragmentation of gallstones by extracorporeal shock waves. World J Surg (1989) 1.42
[Fecal incontinence]. Internist (Berl) (2000) 1.42
Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy. Gastroenterology (1997) 1.41
Serum bile acids: physiology and clinical relevance. Eur J Gastroenterol Hepatol (1995) 1.41
[Experimental ultrasound angioplasty: in vitro resolution of thrombi]. Z Kardiol (1995) 1.40
Biological effects of shock waves: lung hemorrhage by shock waves in dogs--pressure dependence. Ultrasound Med Biol (1987) 1.39
[The diagnosis of ascites]. Dtsch Med Wochenschr (1994) 1.39
[Therapy-refractory thrombocytopenia in chronic hepatitis C]. Z Gastroenterol (2000) 1.39
[The therapy of the hepatorenal syndrome in liver cirrhosis]. Dtsch Med Wochenschr (1999) 1.39
7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology (1996) 1.39
European holiday resorts at risk for Legionella. Lancet (2000) 1.37
Toward defining a neuropsychology of attention deficit-hyperactivity disorder: performance of children and adolescents from a large clinically referred sample. J Consult Clin Psychol (1997) 1.35
Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother (1999) 1.33
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood (1998) 1.32
Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett (1983) 1.32
Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology (1995) 1.32
Breath-hold MR cholangiography with snapshot techniques: prospective comparison with endoscopic retrograde cholangiography. Radiology (1998) 1.32
Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis. Lancet (1995) 1.32
Kinetics of taurocholate uptake by the perfused rat liver. Gastroenterology (1975) 1.30
A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA. Mol Ther (2001) 1.28
Mechanism of cytotoxicity induced by chimeric mouse human monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines. Cell Immunol (2000) 1.28
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27
Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol (1995) 1.27